Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Martin Hoenigl and Oliver Cornely.
Martin Hoenigl
Connection Strength
2.225
Oliver Cornely
  1. Improving outcome of fungal diseases - Guiding experts and patients towards excellence. Mycoses. 2017 Jul; 60(7):420-425.
    View in: PubMed
    Score: 0.716
  2. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel). 2020 Jun 24; 6(2).
    View in: PubMed
    Score: 0.222
  3. Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. J Antimicrob Chemother. 2019 06 01; 74(6):1704-1712.
    View in: PubMed
    Score: 0.206
  4. Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together. Mycoses. 2018 Nov; 61(11):885-894.
    View in: PubMed
    Score: 0.196
  5. Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy. Int J Antimicrob Agents. 2018 Nov; 52(5):706-712.
    View in: PubMed
    Score: 0.195
  6. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses. 2018 May; 61(5):326-330.
    View in: PubMed
    Score: 0.189
  7. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26.
    View in: PubMed
    Score: 0.060
  8. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021 Sep; 64(9):1028-1037.
    View in: PubMed
    Score: 0.060
  9. EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19. Hemasphere. 2021 Jul; 5(7):e612.
    View in: PubMed
    Score: 0.060
  10. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 06; 21(6):e149-e162.
    View in: PubMed
    Score: 0.057
  11. Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa242.
    View in: PubMed
    Score: 0.055
  12. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020 Jun; 1(2):e53-e55.
    View in: PubMed
    Score: 0.055
  13. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). J Antimicrob Chemother. 2019 11 01; 74(11):3315-3327.
    View in: PubMed
    Score: 0.053
  14. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr; 62(4):310-319.
    View in: PubMed
    Score: 0.050
  15. The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model. Mycoses. 2019 Jan; 62(1):16-21.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.